Melanotan II is not approved for any therapeutic use. Here is what the research literature actually says, and how to check a listing.
"Melanotan where to buy" is a search that assumes the product itself is settled and the only open question is the seller. It is worth reversing that assumption. Melanotan II is a synthetic peptide related to a natural skin-pigmentation hormone, and a published overview of melanocortin receptor agonists states plainly that it is not approved for use in any therapeutic indication. This page focuses on Melanotan II specifically, since that is the version the available research and case literature actually addresses, rather than the wider "melanotan" family sometimes referenced online. That framing matters because most of what appears under this search term, whether a dedicated storefront or a single product page inside a wider peptide catalog, is describing the same unapproved compound rather than a range of genuinely different products the way "tirzepatide for sale" actually does. Every check described further down this page applies whether the seller frames the product as a tanning aid, a research compound, or both at once.
Published research describes the mechanism directly: Melanotan II activates a specific melanocortin receptor, MC1R, which stimulates the skin's natural pigment-producing process and intensifies the tanning response to UV exposure. That mechanism is why people seek it out. It has no bearing on whether the compound is approved for any use. None of this description should be read as an endorsement of using the compound for that purpose; it is included here because understanding the mechanism is part of understanding why a market exists for it at all, separate from the question of whether buying it is a good idea. The same research literature is explicit that Melanotan II functions as an unregulated "treatment", its own phrasing, in scare quotes, specifically because there is no approved formulation, no standard dose, and no manufacturer accountable for what actually ships in a given vial.
This matters for how you read any "where to buy" page you find. A product with no approved therapeutic use has no manufacturer running an approved production line, no standard formulation, and no regulator checking batches before they reach a buyer. Every vial in circulation exists outside that system, regardless of what a website says about it. That is true even for listings that use careful, hedged language, research use only, not for human consumption, since the underlying supply chain behind the vial does not change based on the disclaimer printed on the page. The same overview is direct about the conclusion this leads to: people should avoid unlicensed products like this one and should treat any purchase as an unregulated one, whatever the marketing around it claims.
A case report on Melanotan II describes the pattern plainly, noting that the compound is mostly purchased illegally online, with one documented patient obtaining it through a web shop with no pharmacy or prescription involved at either end. That is the default distribution channel, not an edge case. It means the verification problem for a listing selling this compound is close to total: there is no approved reference product to compare a vial against, no manufacturer batch number registered anywhere official, and no regulator inspecting the facility that made it. This is a different situation from a research peptide with an established, if unregulated, base of catalogue suppliers competing on visible lab testing. Melanotan II sits further out on that spectrum, with less competitive pressure toward transparency, because there is no approved reference point for a buyer to compare a seller's claims against in the first place.
One documented case shows what real verification looks like after the fact. After a patient was hospitalized, a forensic laboratory analyzed the injected material and confirmed it was Melanotan II, with no other pharmacological substances present in the specimen. That kind of testing is not something a buyer can arrange before a purchase, but it illustrates exactly what a legitimate, batch-specific Certificate of Analysis is meant to substitute for beforehand: independent confirmation of precisely what is in a given vial, not a general claim printed once and reused for every order. Most buyers will never see that level of testing applied to what they purchase. The realistic substitute is asking a seller for the same kind of independent, batch-specific report this guide expects for every other compound it scores, and treating a refusal, or a generic document, the same way you would treat any other unverifiable claim.
Search for research on Melanotan II and you mostly find individual case reports rather than large trials. One documented report describes a case of renal infarction linked to use. A separate report describes a case of priapism following injection, published specifically because the treating physicians considered the presentation unusual enough to write up. The literature review behind one of these reports lists a wide range of other effects across different body systems, including nausea, abdominal pain, anxiety, flushing, headaches and appetite suppression, alongside the more serious kidney and skin-cancer risks. That range reflects how broadly a nonselective compound like this can act throughout the body, well beyond the pigmentation effect it is bought for. None of these reports establish how common any particular effect is among everyone who has used the compound, since case reports by design only capture instances serious enough to bring someone to a hospital and unusual enough for a physician to write up. That is a real limitation of this kind of evidence, not a reason to dismiss it. It is also how safety information accumulates for a compound with no approved status and no formal post-market monitoring: one clinical case at a time, from doctors treating people after something went wrong, not from a manufacturer's structured safety program. That gap does not support drawing conclusions beyond what the case reports themselves show. It does mean the evidence base here looks nothing like the evidence base behind an approved drug, and a listing that talks about the compound as though it were one is misrepresenting what is actually known.
Because there is no approved supply chain to route around, sourcing for this compound runs through the same kind of research-chemical vendors covered elsewhere on this guide. That does not make every listing equivalent. The distinction that matters is the same one that matters for any research peptide: whether the seller can produce a batch-specific report from an independent lab confirming both what the vial contains and how pure it is, rather than asking you to take a purity percentage on faith. That is a higher bar than it sounds, since a seller with no approved reference product to test against cannot simply point to matching a known standard the way a supplier of an approved-drug analog sometimes can; an independent lab report is effectively the only evidence available at all.
A few checks apply specifically here, on top of the general verification steps in our guide to how to verify a peptide supplier. Be skeptical of any listing that references tanning results, appearance changes or other outcomes, since a product with no approved use should not be marketed on the basis of a health or cosmetic outcome at all. A listing written entirely in general, reassuring language, quality guaranteed, lab tested, without a single specific figure attached, is functionally the same as a listing that says nothing about testing at all. Ask for the batch report by number, not a generic document reused across every order. Treat the absence of a lab name or a verifiable report the same way you would for any other compound: a reason to keep looking, not a detail to overlook because a seller seems established.
This guide scores suppliers on the same criteria regardless of which compound a buyer is asking about: lab testing, delivery, and the guidance a seller actually provides. You can read the method on how we rank and see current results on all scored suppliers. None of that changes the underlying fact for this specific compound: the research consistently describes it as unapproved and largely unregulated in how it reaches buyers, which puts the entire weight of verification on the person placing the order. That weight does not disappear because a seller sounds confident or a website looks professional; neither of those is a substitute for a report you can actually check.
Research-use information only. Not medical advice.